Gaithersburg, MD · Founded 2012 · Privately Held (backing)
Developer of medical drugs designed to halt tumor growth and prevent cancer. Remedy Plan Therapeutics is based in Gaithersburg, MD and was founded in 2012. Its last reported valuation was $55 million in Aug 2023. It has raised $47.6 million.
Last reported valuation
$55.0M
Oct 2026
Priced at
—
Total raised
$47.6M
Last round
—
Cap table — not yet on record
Remedy Plan Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Remedy Plan Therapeutics with a free Private Market View account
·Watch Remedy Plan Therapeutics: the Monday email on marks, rounds and moves
